UTHR
United Therapeutics Corporation
541.70$
-5.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +300.0% | +412.3% | +179.7% | +425.5% | +77.1% | +38.0% | +57.5% | +37.7% | +32.1% | +33.4% | +31.4% | +63.3% | +23.1% | +23.3% | +21.9% | +15.4% | +13.8% | +9.1% | +7.9% | -5.7% | -11.0% | +2.4% | +13.6% | +14.9% | +20.2% | +23.6% | +10.6% | |
| – | – | +21.8% | +83.9% | +73.9% | +24.3% | +21.6% | +49.3% | +38.3% | +30.7% | +35.1% | +50.7% | +62.1% | +21.0% | +34.2% | +9.9% | -4.0% | -45.2% | +5.3% | +45.4% | +88.0% | -40.8% | -8.1% | +13.3% | +19.8% | +75.5% | +20.3% | +24.1% | |
| – | -1,100.0% | – | +655.4% | +850.6% | +88.8% | +40.3% | +58.6% | +37.6% | +32.3% | +33.3% | +29.1% | +63.4% | +23.4% | +21.8% | +23.7% | +17.9% | +20.1% | +9.3% | +6.1% | -11.8% | -6.9% | +3.3% | +13.7% | +14.5% | +15.7% | +24.0% | +9.0% | |
| – | +179.1% | +128.6% | -53.6% | -17.8% | +32.3% | -13.6% | +17.8% | +59.7% | +44.8% | +187.0% | -48.9% | +36.5% | +7.9% | -3.7% | +72.6% | -19.0% | +1.1% | -39.8% | +79.3% | +35.3% | +230.4% | -69.8% | +51.0% | -40.2% | +26.4% | +17.9% | +14.3% | |
| – | – | +134.7% | +44.4% | -32.5% | +98.1% | -5.0% | +14.5% | +119.1% | +83.3% | -4.8% | +87.0% | +13.2% | -21.6% | +28.9% | +95.3% | -24.0% | +19.7% | -35.2% | +14.5% | -22.2% | +33.3% | +33.9% | +9.1% | +3.4% | -5.0% | +37.2% | +12.9% | |
| – | +156.7% | +137.9% | -39.5% | -13.9% | +36.1% | -10.2% | +16.5% | +87.2% | +60.5% | +82.9% | -10.5% | +22.7% | -8.2% | +11.5% | +84.8% | -10.0% | +11.8% | -33.4% | +28.1% | +4.9% | +143.5% | -48.5% | +28.9% | -19.6% | +9.3% | +34.5% | +7.6% | |
| – | – | – | – | – | – | – | +224.7% | -32.4% | -78.3% | -1,401.9% | – | +530.8% | +93.8% | +32.7% | -30.6% | +84.2% | +29.7% | +51.9% | -23.2% | -1.2% | -123.3% | – | -6.4% | +76.2% | +20.9% | +16.2% | +10.2% | |
| – | – | – | +43.9% | -32.3% | -4.3% | -96.4% | +625.0% | +1,562.1% | +351.2% | -99.3% | +80,368.8% | +53.1% | +8.4% | -22.1% | +8.5% | -2.6% | -73.1% | -17.6% | +130.8% | +54.4% | +218.0% | -46.8% | -20.9% | +74.2% | +83.0% | -27.7% | -54.5% | |
| – | – | – | – | – | – | – | +207.6% | -16.0% | -58.4% | -536.0% | – | +687.8% | +102.3% | +47.3% | -36.7% | +88.3% | +98.9% | +1.5% | -27.4% | -1.4% | -121.7% | – | -7.0% | +60.1% | +34.1% | +20.8% | +11.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +95.3% | +66.4% | -23.4% | +77.4% | +112.2% | -11.8% | +1.5% | -51.7% | -135.7% | – | -4.8% | +89.1% | +29.6% | +18.8% | +10.3% | |
| – | – | – | – | – | – | – | +320.8% | +13.8% | -73.2% | -315.5% | – | +444.2% | +105.7% | +39.7% | -42.7% | +94.8% | +91.6% | +9.5% | -41.4% | +41.0% | -117.7% | – | -7.6% | +52.9% | +35.4% | +21.4% | +11.7% | |
| – | – | – | – | – | – | – | +180.8% | -42.1% | -23.5% | -405.4% | – | +331.0% | +83.9% | +42.1% | -33.2% | +77.6% | +88.2% | +0.8% | -3.4% | -20.4% | -108.9% | – | +14.0% | +41.2% | +33.3% | +19.3% | +9.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.